Subscribe to RSS
Acceptance of COVID-19 Vaccination in India, after First Phase-Out: A Cross-Sectional Community-Based Study
Background India rolled out the world's largest vaccination program on January 16, 2021, marking the beginning of an effort to vaccinate a population of 1.3 billion against coronavirus disease 2019 (COVID-19) infection. However, the hesitancy toward safe and effective vaccine against severe infection is a major global health threat. Hence, public acceptance of COVID-19 vaccine would be an essential deterrent to the pandemic control.
Materials and Methods A cross-sectional online study was conducted among the Indians from January 1 to January 31, 2021. The online questionnaire addressed several variables, including the sociodemographic parameters, COVID-19 vaccine acceptance, and concerns regarding COVID-19 vaccine.
Results Out of total 450 participants, majority of them (97.1) were aware about the COVID-19 vaccination drive. Only 66.2% showed their willingness to accept vaccination, 26.0% were still indecisive, and 7.8% did not want to accept it.
Conclusion Despite numerous efforts by various scientific organizations, public health experts, and media outlets, to educate the general population about the COVID-19 vaccine, significant portion of the Indian population may experience vaccine hesitancy, which poses dangers to both the individual and their community. Therefore, we must target these potential candidates, who are indecisive, for intervention to increase vaccine acceptance across the country. In this regard, large-scale study is required to understand the knowledge, expectation, and apprehension covering various economic and occupational strata of the society.
Article published online:
07 March 2022
© 2022. National Academy of Medical Sciences (India). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Coronavirus disease 2019 (COVID-19) Situation Report – 94. Accessed April 23, 2020 at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200423-sitrep-94-covid-19.pdf
- 2 IndiaFightsCorona COVID-19 in India, Vaccination, Dashboard, Corona Virus Tracker. Available at: https://www.mygov.in/covid-19
- 3 National Academies of Sciences, Engineering, and Medicine. (2020). Framework for equitable allocation of COVID-19 vaccine. Accessed January 19, 2022 at: //www.nap.edu/catalog/25917/framework-for-equitable-allocation-of-covid-19-vaccine
- 4 McAteer J, Yildirim I, Chahroudi A. The VACCINES Act: deciphering vaccine hesitancy in the time of COVID-19. Clin Infect Dis 2020; 71 (15) 703-705
- 5 World Health Organizations. (2019). Ten threats to global health in 2019. Accessed January 19, 2022 at: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019
- 6 MacDonald NE. SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 2015; 33 (34) 4161-4164
- 7 World Health Organization. Department of Immunization, Vaccines and Biologicals (IVB). SAGE October 2014. Geneva: World Health Organization; 2014 ; Accessed January 19, 2022 at: http://www.who.int/immunization/sage/meetings/2014/october/Yellow-bookSAGE2014_final.pdf?ua=1
- 8 Sharun K, Rahman F, Haritha V, Jose B, Tiwari R, Dhama K. COVID-19 vaccine acceptance: beliefs and barriers associated with vaccination among the general population in India. J Experiment Biol Agricult Sci. 2020; 8: S210-S218
- 9 Islam F, Agarwalla R, Panda M. et al. Assessment of the knowledge, preferences and concern regarding the prospective COVID- 19 vaccine among adults residing in New Delhi, India-a cross sectional study. [Internet]. DOI: 10.1101/2021.01.23.21250164. Accessed January 19, 2022
- 10 Fu C, Wei Z, Pei S, Li S, Sun X, Liu P. Acceptance and preference for COVID-19 vaccination in health-care workers (HCWs) [Internet]. Epidemiology 2020. Accessed January 19, 2022 at: http://medrxiv.org/lookup/doi/10.1101/2020.04.09.20060103
- 11 Nguyen T, Henningsen KH, Brehaut JC, Hoe E, Wilson K. Acceptance of a pandemic influenza vaccine: a systematic review of surveys of the general public. Infect Drug Resist 2011; 4: 197-207
- 12 Gidengil CA, Parker AM, Zikmund-Fisher BJ. Trends in risk perceptions and vaccination intentions: a longitudinal study of the first year of the H1N1 pandemic. Am J Public Health 2012; 102 (04) 672-679
- 13 Setbon M, Raude J. Factors in vaccination intention against the pandemic influenza A/H1N1. Eur J Public Health 2010; 20 (05) 490-494
- 14 Quinn SC, Jamison AM, An J, Hancock GR, Freimuth VS. Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: results of a national survey of White and African American adults. Vaccine 2019; 37 (09) 1168-1173
- 15 Musa D, Schulz R, Harris R, Silverman M, Thomas SB. Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health 2009; 99 (07) 1293-1299
- 16 Harris KM, Maurer J, Kellermann AL. Influenza vaccine–safe, effective, and mistrusted. N Engl J Med 2010; 363 (23) 2183-2185
- 17 Shore DA. Communicating in times of uncertainty: the need for trust. J Health Commun 2003; 8 (Suppl. 01) 13-14
- 18 French J, Deshpande S, Evans W, Obregon R. Key guidelines in developing a pre-emptive COVID-19 vaccination uptake promotion strategy. Int J Environ Res Public Health 2020; 17 (16) E5893